Related Experiment Videos

LDH isoenzymes in CSF in the diagnosis of neonatal brain damage

Insights

Elevated lactate dehydrogenase (LDH) isoenzymes LDH2 and LDH3 in cerebrospinal fluid may indicate anoxic brain damage in newborns. Higher levels correlate with poorer outcomes in asphyctic infants.

Area of Science:

  • Biochemistry
  • Neonatal Medicine
  • Neurology

Background:

  • Hypoxic-ischemic encephalopathy (HIE) is a major cause of neonatal mortality and morbidity.
  • Cerebrospinal fluid (CSF) biomarkers are crucial for diagnosing and assessing brain injury in neonates.

Purpose of the Study:

  • To investigate the diagnostic value of lactate dehydrogenase (LDH) isoenzymes in CSF for assessing anoxic brain damage in neonates.
  • To correlate CSF LDH isoenzyme patterns with clinical outcomes in asphyctic neonates.

Main Methods:

  • Measurement of LDH isoenzymes (LDH1-5) in CSF within the first 24 hours of life.
  • Clinical and developmental follow-up examinations for a mean period of 15.2 months.
  • Comparison of LDH isoenzyme levels between neonates with different outcomes (death, neurological sequelae, normal survival).

Main Results:

  • Significantly higher mean values of LDH2 and LDH3 isoenzymes were observed in asphyctic neonates who died from HIE or survived with neurological sequelae.
  • Asphyctic neonates who survived without neurological deficits showed lower CSF LDH2 and LDH3 levels compared to those with adverse outcomes.

Conclusions:

  • The pattern of lactate dehydrogenase isoenzymes in cerebrospinal fluid can serve as a valuable indicator for assessing anoxic brain damage in neonates.
  • CSF LDH isoenzyme analysis may aid in predicting neurological outcomes in infants affected by perinatal asphyxia.

Related Concept Videos